Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Anabolic signaling pathways collectively refer to intracellular molecular cascades that direct cells to increase biosynthetic activities, including synthesis of proteins, lipids, nucleic acids, and glycogen[1][3][5]. Major anabolic pathways include the PI3K/AKT/mTOR cascade, which is activated by growth factors (such as insulin and IGF-1) binding to their receptors, and leads to increased cellular uptake of nutrients and promotion of protein and lipid synthesis[1][3][4]. These pathways play essential roles in tissue growth, maintenance, and repair, especially in skeletal muscle, and are opposed by catabolic signaling such as AMPK activation[1][2][4]. Dysregulation of anabolic signaling is implicated in diseases like cancer and metabolic disorders[1][2][4][5]. However, because anabolic signaling pathways refer to functional networks, not a unique, well-defined therapeutic target or single molecule, this term is not suitable for entries that require specificity at the level of a protein, receptor, transporter, or enzyme[1][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Anabolic signaling pathways.